Dose-Escalation Study of ALXN1210 IV in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical trial NCT02598583 · COMPLETED
Trial details
- NCT number
- NCT02598583
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-12
- Primary completion
- 2016-07-14
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.